Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|May 15, 2013
Monoamine oxidases are mediators of endothelial dysfunction in the mouse aortaAdrian Sturza, Matthias S Leisegang, Andrea Babelova, et al.
The Journal of Clinical Investigation|November 19, 2010
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritisKristin Moreth, Rebekka Brodbeck, Andrea Babelova, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2005
Nitric oxide upregulates induction of PDGF receptor-alpha expression in rat renal mesangial cells and in anti-Thy-1 glomerulonephritisKarl-Friedrich Beck, Gülmisal Güder, Liliana Schaefer, et al.
Free Radical Biology & Medicine|October 10, 2013
Endo-PDI is required for TNFα-induced angiogenesisLivia de Lucca Camargo, Andrea Babelova, Anja Mieth, et al.
Free Radical Biology & Medicine|July 4, 2012
Role of Nox4 in murine models of kidney diseaseAndrea Babelova, Despina Avaniadi, Oliver Jung, et al.
The American Journal of Pathology|January 4, 2007
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycinLiliana Schaefer, Wasiliki Tsalastra, Andrea Babelova, et al.
Plos One|November 19, 2013
Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney diseaseAndrea Babelova, Felix Jansen, Kerstin Sander, et al.
The Journal of Biological Chemistry|July 17, 2009
Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptorsAndrea Babelova, Kristin Moreth, Wasiliki Tsalastra-Greul, et al.
The American Journal of Pathology|July 28, 2004
Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injuryLiliana Schaefer, Daniel Mihalik, Andrea Babelova, et al.
American Journal of Physiology. Cell Physiology|June 3, 2024
ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cellsVeronika Nemethova, Petra Babiakova, Boglarka Teglasova, et al.
Pageof 4